title: Response to Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection".
abstract: Ebselen's antivirulence activity in Clostridium difficile infection is likely due to multiple modes of action, but the contribution of each to its efficacy remains unclear.
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Kristina Oresic
authors.initials: KO
authors.lastname: Bender
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Garland
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. mbogyo@stanford.edu.
authors.forename: Matthew
authors.initials: M
authors.lastname: Bogyo
mesh_terms: D016360:Clostridioides difficile; D003015:Clostridium Infections; D006801:Humans